Member Info for rhwillcoll

I would far rather be in than out, with this international webinar about to be shown.

TopicR42-AlgoDynamix: Markets or Mania

DescriptionJoin financial innovation leaders Dr. Jeremy Sosabowski (AlgoDynamix CEO), Prof. Ronjon Nag (R42 Founder), and Prof. Frank Sortino (Sortino ratio creator) as they decode whether we're witnessing rational markets or investment mania. Gain valuable insights on risk management strategies that could reshape your investment approach.

see R42 website to register

Dream Theater, no problem at all.

Have a great day.

I agree with what you have said, Dream Theater. However, may I change your simile to "price will take off like a Persian Carpet in the Middle East, as the bomb remark was too close for comfort!

Thank you, anyway. I have remained in hear with my shed load of shares throughout, as have many others I am sure. Most of us are not rainbow chasing day traders - well I sincerely hope not!

Are there still warrants going through the system, or not?

Am I correct in thinking that there are still warrants being flushed through the system? It looks like it to me. Obviously only a temporary phase.

What happens when the MMs run out of shares?

Oh sorry, they already have 😃

Christian eschatology indicates that the second coming of Jesus Christ will occur after a certain length of time. The first coming was correct: 350 Old Testament prophecies refer to this. There are around 500 prophecies about the second coming.

So basically, no need to be too concerned about living forever.

However, I think that the medical advances being proposed by Dr Nag via AI are really great, and it is to be greatly hoped that much suffering can be spared by many more people able to live longer but with much less pain.

All the best for the coming week.

Crownos, many thanks from myself also for a really great post. Really helpful as always, and much appreciated.

I've just seen that in the vote for medicine, prevention of brain aging won the majority of the vote. I wonder if say we will start off say with two from each of media and two from medicine, or maybe even three from each, or four? How exciting all this is! Plus fast incubation of just a year or whatever. It is all quite extraordinary!

Have a great weekend, fellow investors!

No trades have been reported for a good half hour - that's also strange.

Mr rabbithole, I think that is calling "squirrelling " away, down your "warren" - well done 😃

Thankfully, these warrants are a VERY temporary phenomenon.

Interesting that there is only 100 out of the 400 million of these left, if that is indeed the case.

What role does Dr. Nag see for autonomous models in future biomedical research

The future landscape of large language models in medicine ...

In the future, an AI may eg diagnose eye problems

Navigating artificial general intelligence development ...

The Future of Healthcare

Dr. Ronjon Nag envisions autonomous AI models playing a transformative role in biomedical research by democratizing access to advanced tools and accelerating discovery. His work on Superbio.ai—a no-code AI platform for life sciences—reflects this vision through several key principles:

1. Democratization of AI

Autonomous models enable researchers without coding expertise to deploy AI for tasks like drug discovery, genomic analysis, and clinical trial optimization. Superbio.ai’s open marketplace allows scientists to share pre-trained models, reducing barriers to entry.

2. Reproducibility and Standardization

Autonomous systems could address reproducibility crises by enforcing standardized protocols and automating data analysis. This aligns with Superbio.ai’s focus on creating reusable, validated workflows for biological research.

3. Accelerated Innovation

By automating routine tasks (e.g., image analysis, literature reviews), AI models free researchers to focus on hypothesis generation and interdisciplinary collaboration. This mirrors broader trends in AI-driven scientific discovery highlighted in the Royal Society’s report.

4. Ethical and Equitable Implementation

While not explicitly stated by Dr. Nag, his platforms emphasize transparency and accessibility—key factors in mitigating algorithmic bias and ensuring AI benefits diverse populations. Superbio.ai’s academic-free tier supports this equitable approach.

Challenges Addressed

Skill gaps: Autonomous models reduce reliance on specialized programming knowledge.

Resource limitations: Cloud-based AI optimizes computational efficiency, critical for underfunded labs.

Dr. Nag’s initiatives suggest he sees autonomous AI as a catalyst for a paradigm shift—where collaborative, AI-augmented research becomes the norm rather than the exception.

Thank you Muck165 and Crownos: great thinking and an excellent discussion. I have just run Superbio.ai through my perplexity app and this is what comes up. I trust that this may be of some help. My only comment: what immense, extraordinary and world changing vision we have with Dr Nag!:

Superbio.ai Overview

Superbio.ai is the world's first no-code, community-driven AI app store for life sciences and biology. It allows scientists and researchers—regardless of programming experience—to access, implement, and share AI models and bioinformatics tools via a cloud-based platform.

Key Features:

No-code interface for deploying AI in biology.

Open marketplace where researchers can submit, share, and monetize their AI models and tools.

Focus on reproducibility and standardization in life sciences research.

Free access for academia; industry users are onboarded through partnerships and beta-testing.

Environmentally friendly by optimizing cloud computation and reducing the need for energy-intensive model training.

Leadership:

Superbio.ai was co-founded by Dr. Ronjon Nag (Chairman) and launched as a project to make AI accessible for biologists, accelerating machine learning adoption in drug development and other biomedical fields.

Vision:

To unite the life sciences community, standardize AI-driven research, and enable rapid, reproducible scientific progress through a user-friendly, collaborative platform.

Simon, they are already working on skin cancer - that is the Silicon Valley R42 group, plus a whole pile of other cancers.

All the best

43 million trades posted after hours!

Thank you so much, Muck165 - a brilliant further post. You've hit the nail on the head I think! So, we could "almost" say:

CPAI is an "AI Digital Book Publishing Company" - just one of its projects! How fascinating and money-making is that!!

Well done, Sir!!

Thank you Muck165, what a great find! Here is the Market Size of AI in Book Publishing, according to my Perplexity App. Absolutely massive and just one of CPAI's projects:

Market Size of AI in Book Publishing

The global AI in publishing market was valued at approximately USD 3.58 billion in 2024 and is projected to reach USD 30.4–41.2 billion by 2032–2033, with a compound annual growth rate (CAGR) of around 31%.

This market includes all uses of AI in publishing, such as automated content creation, editing, personalization, and workflow optimization.

AI’s role in book publishing specifically is rapidly expanding, with over 70% of self-published authors now using AI or digital tools to speed up the publishing process.

The self-publishing sector alone reached USD 1.25 billion in 2022, driven in large part by AI advancements.

Key Trends

AI tools are automating editing, formatting, cover design, and even audiobook creation, significantly reducing production times.

Startups like Spines are aiming to publish thousands of books per year using AI, demonstrating the technology’s scalability in book publishing.

Despite rapid growth, only about 12–15% of top publishers have fully adopted advanced AI tools, indicating substantial room for further expansion.

In summary, the AI market in book publishing is growing quickly, with billions in current value and strong double-digit annual growth expected through the next decade.

Obviously nobody will ring a bell when the bottom is reached. But I would think that we are almost there. Anything bought below 1p is an absolute steal. This is all fine, all part of the process.

I'm liking everything about this company. Dr Nag and what he is doing. Multi-AI projects being worked upon and finalised. CPAI having rights of first refusal. I love the arenas of Media and Medicine, including the five key AI areas that they have mentioned: each one being a multi-billion industry.

Just to say: lots and lots of buys this morning, but in between quite a few 1 mn sales. I do think that these are the warrants being worked through. So, warrants going through, but lots of buys soaking them up. That is my "take" on what is happening today. I understand that this warrant process is very limited, so a great buying opportunity right now, and prices around this and then to go right up after these sales have been completed. Is that how others see it? Either way, I'm staying here and sticking here. Enjoy the rest of your day, folks.

L2 is looking great. Boomerang time I think.